Izigaba ezikhethekile ze-apis, njengesisekelo se-API, zihluke kakhulu ku-apis ezinkulu zendabuko. Igxile emithini enamalungelo obunikazi angakaphumi noma leyo enezidingo ezikhethekile zokwelapha. Ucwaningo nokuthuthukiswa kanye nokukhiqiza kunzima kakhulu, futhi izithiyo zobuchwepheshe ziqinile njengedwala, okwenza kube nezindleko eziphezulu. Ngokwembono yokusebenza, ama-apis akhethekile abamba iqhaza elikhulu emikhakheni eminingi yokwelapha efana nokulwa ne-tumor, izifo zenhliziyo, kanye nokwelashwa kwengqondo nezokwelapha. Le mikhakha ihlobene kakhulu nezidingo eziyisisekelo zempilo yomuntu futhi inezidingo eziqinile kakhulu mayelana nokusebenza kahle nokuphepha kwemithi. ​

Take anti-tumor drugs as an example. The precision and purity of characteristic raw materials directly affect the therapeutic effect of anti-cancer drugs and the quality of life of patients. Globally, with the acceleration of the aging process of the population and the rising incidence of chronic diseases, the market demand for characteristic apis is showing a rapid growth trend. According to relevant data, in the past few years, the global market size of specialty apis has been steadily expanding at an annual rate of [X]%, demonstrating strong market vitality and potential. ​

Mu myaka yashize, Ubushinwa bwageze ku iterambere rikomeye mu rwego rw'ibikoresho by'ibiyobyabwenge bifite umwihariko. Ibigo byo mu gihugu, byishingikirije ku bushobozi bwabo bw'ubushakashatsi n'iterambere bukomeje kwiyongera n'ikoranabuhanga, byagiye bisenya imiterere y'ubukungu mpuzamahanga, bigaragara ku isoko mpuzamahanga, kandi igice cyabo ku isoko gikomeje kwaguka. Ariko, tugomba kandi kumenya neza ko iterambere ry'uru rwego ritakiri mu nzira nziza kandi rihura n'ibibazo byinshi bikomeye. Ku ruhande rumwe, guhangana ku isoko mpuzamahanga birakomeje kuba bibi. Ibigo by'ibiyobyabwenge byo mu bihugu bitandukanye byose byiyongera ku ishoramari ryabo mu bushakashatsi n'iterambere kugira ngo bihangane ku musaruro muke w'isoko. Ku rundi ruhande, inzego zishinzwe kugenzura imiti zifite ibisabwa bikomeye ku bipimo by'ubuziranenge n'umutekano w'ibikoresho by'ibiyobyabwenge bifite umwihariko, bigatanga ikizamini gikomeye ku buryo bwo gukora n'imiyoborere y'ubuziranenge y'ibigo. ​

In this industry wave full of opportunities and challenges, Chuzhou Qingyun Pharmaceutical Co., Ltd. stands at the forefront and actively engages in the research and development and production of characteristic raw materials. Since its establishment in 2016, the company has always regarded innovation as the core driving force for its development. It has formed a professional R&D team led by senior scientific research experts. Team members, relying on their profound professional knowledge and rich practical experience, focus on the cutting-edge technology research and process optimization of characteristic active pharmaceutical ingredients. At present, the company has made significant breakthroughs in multiple characteristic raw material drug varieties. The key technical indicators of some products have reached the international advanced level. Not only has the goal of domestic substitution for imported products been achieved, but it has also successfully entered the international market and won high praise and trust from domestic and foreign customers.